Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06869044 · ClinicalTrials.gov registry record · NA

A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add

A NA study of Myopia and Presbyopia, sponsored by CooperVision International Limited (CVIL).

Recruiting
Registry status
NA
Development phase
66
Enrollment target
1
Study location

NCT06869044 is a NA study of Myopia and Presbyopia that is actively recruiting participants, run by CooperVision International Limited (CVIL). The registered enrollment target is 66 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06869044, a NA study of Myopia and Presbyopia, is actively recruiting participants, sponsored by CooperVision International Limited (CVIL).

RECRUITING
Registry status
NA
Development phase
66 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to compare the overall lens satisfaction between two soft multifocal contact lenses.

Interventions

  • DEVICE omafilcon A lens
  • DEVICE Low ADD power somofilcon A lens
  • DEVICE Medium ADD power somofilcon A lens
  • DEVICE High ADD power somofilcon A lens

Study Locations (1)

California

  • University of California, Berkeley, CA - Berkeley

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2025-02-11
Est. Completion 2025-04-30
Phase NA

What the Registry Record Tells You About NCT06869044

The ClinicalTrials.gov registry entry for NCT06869044 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (75% lower). The listed sponsor is CooperVision International Limited (CVIL), which has 11 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Myopia appearing as the primary indexed condition, and to 4 interventions - of which omafilcon A lens is the first listed.

NCT06869044 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06869044 about?

NCT06869044 is a clinical study titled "A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add". The aim of this study is to compare the overall lens satisfaction between two soft multifocal contact lenses.

What is the current status of trial NCT06869044?

This trial is currently recruiting. It is a NA study. The enrollment target is 66 participants. The study started on 2025-02-11. Estimated completion is 2025-04-30.

What conditions does trial NCT06869044 study?

This clinical trial studies the following conditions: Myopia, Presbyopia, Hyperopia.

What interventions are being tested in trial NCT06869044?

The interventions under investigation include: omafilcon A lens (DEVICE), Low ADD power somofilcon A lens (DEVICE), Medium ADD power somofilcon A lens (DEVICE), High ADD power somofilcon A lens (DEVICE).

Who is sponsoring clinical trial NCT06869044?

This trial is sponsored by CooperVision International Limited (CVIL), which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06869044 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.